用于再生医学和化品的药物再利用:科学,技术和经济问题
Thuy-Duong Vu1, Duc Tri Luong1, Thuy-Tien Ho1
1Center for Biomedicine and Community Health, International School, Vietnam National University, Hanoi, Vietnam.
Progress in molecular biology and translational science
|June 28, 2024
概括
药物重新定位提供了一个有希望的解决方案,通过重新定位现有的药物来加速再生医学和化品中的药物发现. 这种方法解决了财务和时间的挑战,导致成功进入市场,如minoxidil.
科学领域:
- 药物发现 药物发现
- 再生医学是一种再生医学.
- 化品 化品 化品
背景情况:
- 再生医学和化品是药物发现的关键领域,面临着巨大的财务和时间限制.
- 药物重新定位,利用已批准的药物进行新的治疗用途,成为克服这些挑战的可行策略.
研究的目的:
- 探索药物重新定位在再生医学和化品中的潜力.
- 突出与这种方法相关的好处和挑战.
主要方法:
- 审查这些领域对药物重新定位的科学证据.
- 检查用于识别重用药物候选者的计算方法.
- 分析重定向药物的成功例子.
主要成果:
- 药物重新定位已经证明在再生医学和化品中具有适用性.
- 计算方法有助于发现重新定位的新候选者.
- 几种重新设计的药物,如米诺克西迪尔和芬戈利莫德,已经取得了市场上的成功.
结论:
- 药物重新定位对再生医学和化品具有不可否认的好处.
- 需要进一步考虑临床试验的有效性,专利法规,数据管理和环境影响.
相关概念视频
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Induced Pluripotent Stem Cells
4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.0K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Stem Cell Culture
5.1K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.1K


